L

Lucid Diagnostics
D

LUCD

0.84450
USD
0.05
(5.91%)
Post Trading·0.86500USD+0.02050(+2.43%)
حجم التداول
32,566
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
161,256,202
المقالات
المزيد

العنوان: Lucid Diagnostics

القطاع: الرعاية الصحية
الصناعة: Medical Devices
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.